Clinical Study
Evaluation of the Macular, Peripapillary Nerve Fiber Layer and Choroid Thickness Changes in Behçet’s Disease with Spectral-Domain OCT
Table 2
Thickness of macula in patients with BD and controls.
| Variables | Groups | Ocular Involvement | Control () | Behcet () | | Present () | Absent () | |
| CSF | 269.30 ± 20.05 | 266.76 ± 22.87 | 0.425 | 266 ± 23.07 | 269 ± 20.51 | 0.606 | SIM | 348.75 ± 16.48 | 340.95 ± 19.37 | 0.004 | 336.41 ± 18.17 | 342.05 ± 19.25 | 0.271 | TIM | 333.46 ± 14.00 | 326.41 ± 16.85 | 0.003 | 327.73 ± 15.3 | 326.84 ± 16.26 | 0.836 | IIM | 342.57 ± 18.77 | 336.47 ± 20.80 | 0.038 | 336.86 ± 17.96 | 335.81 ± 26.53 | 0.870 | NIM | 348.28 ± 14.12 | 338.38 ± 22.48 | <0.001 | 338.68 ± 21.68 | 339.62 ± 21.03 | 0870 | SOM | 301.03 ± 15.21 | 294.23 ± 17.93 | 0.006 | 287.95 ± 16.94 | 297.43 ± 15.31 | 0.031 | TOM | 288.47 ± 15.16 | 283.90 ± 20.09 | 0.089 | 279 ± 16.46 | 286.3 ± 14.42 | 0.080 | IOM | 294.44 ± 16.53 | 287.95 ± 19.26 | 0.016 | 285 ± 31.15 | 289.97 ± 14.83 | 0.488 | NOM | 319.07 ± 15.07 | 310.18 ± 20.10 | 0.001 | 305.64 ± 17.84 | 312.24 ± 21.13 | 0.224 | FOVEA | 226.46 ± 24.78 | 225.59 ± 30.67 | 0.492 | 218.18 ± 25.83 | 230.16 ± 31.2 | 0.135 |
|
|
Values are expressed as mean ± SD; : number of case; CSF: central subfield; SIM: superior inner macula; TIM: temporal inner macula; IIM: inferior inner macula; NIM: nasal inner macula; SOM: superior outer macula; TOM: temporal outer macula; IOM: inferior outer macula; NOM: nasal outer macula.
|